Trials / Sponsors / Treadwell Therapeutics, Inc
Treadwell Therapeutics, Inc
Industry · 3 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Active Not Recruiting | CFI-402257, a Potent and Selective TTK Inhibitor, in Solid Tumors and With Fulvestrant in Breast Cancer Advanced Solid Tumor, Breast Cancer | Phase 1 / Phase 2 | 2022-05-27 |
| Active Not Recruiting | A Study of CFI-400945 With or Without Azacitidine in Patients With AML, MDS or CMML Acute Myeloid Leukemia, Myelodysplastic Syndromes, Chronic Myelomonocytic Leukemia | Phase 1 / Phase 2 | 2021-04-16 |
| Active Not Recruiting | Safety and Efficacy Study of CFI-402411 in Subjects With Advanced Solid Malignancies Advanced Solid Malignancies | Phase 1 / Phase 2 | 2020-08-31 |